Akoya Biosciences
Akoya Biosciences Licenses Early-Stage Melanoma Test From NeraCare
The exclusive license agreement builds on an existing research collaboration between the companies to develop assays for skin cancer using Akoya's immunofluorescence platform.
Akoya Biosciences, NeraCare Partner to Develop Melanoma Tests
The companies will develop tests for patient stratification and therapy selection for early melanoma using the PhenoImager HT platform and Immunoprint assay.
Evolving Akoya Biosciences Touts CDx Partnerships at JP Morgan Conference
The Marlborough, Massachusetts-based firm also announced new panels for its PhenoCycler-Fusion and PhenoImager HT spatial analysis platforms.
Agilent, Akoya to Commercialize Workflow Tools for Tissue Biomarker Analysis
The end-to-end workflow products are intended for biopharmaceutical companies developing companion diagnostics for precision cancer therapeutics.
Akoya Biosciences, Acrivon Therapeutics Partner to Develop CDx
The companies will codevelop, validate, and commercialize a companion diagnostic for Acrivon's targeted DNA damage response inhibitor therapy, ACR-368.